首页> 外国专利> PHARMACEUTICAL FORMULATION HAVING IMPROVED DISSOLUTION RATE AND STABILITY FOR ORAL ADMINISTRATION CONTAINING PELUBIPROFEN

PHARMACEUTICAL FORMULATION HAVING IMPROVED DISSOLUTION RATE AND STABILITY FOR ORAL ADMINISTRATION CONTAINING PELUBIPROFEN

机译:药物配方中溶出率和稳定性均得到改善

摘要

PURPOSE: one kind pelubiprofen containing oral formulation is provided to improve release rate and stability, by reducing impurity and to ensure snap action and bioavilability. ;CONSTITUTION: medicinal preparation for oral administration with improved release rate and stability pelubiprofen include chemical formula 1 have average particle size be 1-30 uh be used as active constituent. The pharmaceutical preparation also contains excipient, lactose, calcium monohydrogen phosphate, starch or polyalcohol, the hydroxy propyl cellulose or polysaccharide of binder, the magnesium stearate or talcum of disintegrating agent carboxymethyl base cellulose calcium, low substituted hydroxypropyl cellulose or starch or lubricant. The polyalcohol is mannitol, isomalt or xylitol. Polysaccharide xanthan gum or carragheen. The form of the pharmaceutical preparation to use tablet, granule, capsule or dry syrup. ;The 2010 of copyright KIPO submissions
机译:目的:提供一种含培比洛芬的口服制剂,可通过减少杂质并确保速效和生物活性来提高释放速率和稳定性。 ;组成:口服制剂,具有改善的释放速率和稳定性,贝洛洛芬包括化学式1,平均粒径为1-30 uh,用作活性成分。该药物制剂还包含赋形剂,乳糖,磷酸一氢钙,淀粉或多元醇,粘合剂的羟丙基纤维素或多糖,崩解剂羧甲基基础纤维素钙的硬脂酸镁或滑石,低取代的羟丙基纤维素或淀粉或润滑剂。多元醇是甘露醇,异麦芽酮糖或木糖醇。多糖黄原胶或角叉菜胶。药物制剂的形式可以使用片剂,颗粒剂,胶囊剂或干糖浆。 ; 2010年版权KIPO提交文件

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号